SOUTHWEST ONCOLOGY GROUP

西南肿瘤集团

• 批准号: 3556197
• 负责人: THOMAS Patrick MILLER
• 金额: $ 25.27万
• 依托单位: UNIVERSITY OF ARIZONA
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-01-01 至 1987-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3556197
• 关键词: Hodgkin's disease; adult human (21+); bleomycin; breast neoplasms; carmustine; combination cancer therapy; cooperative study; cyclophosphamide; doxorubicin; drug metabolism; fluorouracil; gastrointestinal neoplasms; head /neck neoplasm; human subject; human therapy evaluation; leukemia; lung neoplasms; lymphoma; melphalan; metastasis; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer radionuclide diagnosis; ovary neoplasms; pediatric neoplasm /cancer; prednisone; radiotracer; sarcoma; testis neoplasms; vincristine

We plan to continue our investigations of multimodality treatment of cancer in man through the Southwest Oncology Group (SWOG). Investigators from Arizona currently coordinate 26 clinical trials (17 phase II and 9 phase III). Investigators from Arizona serve as chairmen of three scientific disease committees (Lymphoma, Myeloma and Gynecologic Oncology. Arizona investigators are providing major scientific expertise and improved treatment results in several tumor types (myeloma, lymphoma, lung cancer, gynecologic cancer, melanoma) as well as in the areas of anticancer agent pharmacology, tumor cloning and hematopathology. We registered 184 patients on studies in 1982. Investigators from Arizona have published 74 manuscripts relative to SWOG research. Funds are needed to support the disciplines of medical oncology, radiation oncology, surgery, pathology, and a stem cell laboratory for SWOG.

我们计划继续对癌症的多模式治疗进行调查 通过西南肿瘤学小组（Swog）在人中。 来自 亚利桑那州目前协调26个临床试验（17期和9期 iii）。 亚利桑那州的调查人员担任三位科学的主席 疾病委员会（淋巴瘤，骨髓瘤和妇科肿瘤学。亚利桑那州 研究人员正在提供主要的科学专业知识并改善 治疗导致几种肿瘤类型（骨髓瘤，淋巴瘤，肺癌， 妇科癌，黑色素瘤）以及抗癌剂的区域 药理学，肿瘤克隆和血液病理学。 我们注册了184 1982年研究的患者。亚利桑那州的研究人员发表了74名 手稿相对于摇摆研究。 需要资金来支持 医学肿瘤学，放射肿瘤学，手术，病理学的学科 和一个用于吞咽的干细胞实验室。